Senator probes Medtronic, FDA on defibrillator leads

Medtronic and the FDA received letters from Sen. Chuck Grassley, R-Iowa, and the consumer group Public Citizen regarding safety concerns over the Sprint Fidelis defibrillator leads, which have a potential for fractures. Medtronic has halted the sales of the leads, citing its primary concern for patient safety and well-being.

View Full Article in:

Wall Street Journal (free content), The · Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI